FINAL REFUSAL - MAILED
mailed
on 12 Jun 2024
Last Applicant/ Owned by
2 Tower Center Boulevard Suite 1401A
East Brunswick
NJ
08816
Serial Number
98126359 filed on 10th Aug 2023
Registration Number
N/A
Correspondent Address
Antonio PAPAGEORGIOU
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
RISING HEALTH
HEALTH Topical medical preparations for the treatment of a variety of skin irritations and skin diseases; Medical preparations, namely, antiseptic ointment and skin protectant; Anti-itch cream; Anti-inflammatory ointment; Dietary supplements; Nutritional supplements; Allergy medication; Multi-vitamin preparations; Vitamin and mineral supplements; Medicated diaper rash ointment; Anti-cavity dental Read More
Classification Information
Class [035]
Advertising, Business & Retail Services
Topical medical preparations for the treatment of a variety of skin irritations and skin diseases; Medical preparations, namely, antiseptic ointment and skin protectant; Anti-itch cream; Anti-inflammatory ointment; Dietary supplements; Nutritional supplements; Allergy medication; Multi-vitamin preparations; Vitamin and mineral supplements; Medicated diaper rash ointment; Anti-cavity dental coating preparations containing fluoride
First Use Date in General
28th Sep 2021
First Use Date in Commerce
28th Sep 2021
Mark Details
Serial Number
No 98126359
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 12th Jun 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 12th Jun 2024 | FINAL REFUSAL E-MAILED |
| 12th Jun 2024 | FINAL REFUSAL WRITTEN |
| 06th May 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 06th May 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 06th May 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 06th Feb 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 06th Feb 2024 | NON-FINAL ACTION E-MAILED |
| 06th Feb 2024 | NON-FINAL ACTION WRITTEN |
| 30th Jan 2024 | ASSIGNED TO EXAMINER |